Cargando…

ULK1 in type I interferon response

Detalles Bibliográficos
Autores principales:	Saleiro, Diana, Platanias, Leonidas C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694774/ https://www.ncbi.nlm.nih.gov/pubmed/26309084

Ejemplares similares

Type I and II Interferons in the Anti-Tumor Immune Response
por: Fenton, Sarah E., et al.
Publicado: (2021)

Regulation of IFNα-induced expression of the short ACE2 isoform by ULK1
por: Perez, Ricardo E., et al.
Publicado: (2022)

Human SLFN5 is a Transcriptional Co-repressor of STAT1-Mediated Interferon Responses and Promotes the Malignant Phenotype in Glioblastoma
por: Arslan, Ahmet Dirim, et al.
Publicado: (2017)

Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
por: Mazewski, Candice, et al.
Publicado: (2020)

Deregulation of Interferon Signaling in Malignant Cells
por: Katsoulidis, Efstratios, et al.
Publicado: (2010)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms
por: Saleiro, Diana, et al.
Publicado: (2022)

Targeting Cytokines and Their Pathways for the Treatment of Cancer
por: Heimberger, Amy B., et al.
Publicado: (2023)

Ulk1, Not Ulk2, Is Required for Exercise Training-Induced Improvement of Insulin Response in Skeletal Muscle
por: Drake, Joshua C., et al.
Publicado: (2021)

The ingenious ULKs: expanding the repertoire of the ULK complex with phosphoproteomics
por: Mercer, Thomas J., et al.
Publicado: (2021)

ULK1 cycling: The ups and downs of the autophagy response
por: Zhao, Yan G., et al.
Publicado: (2016)

The incredible ULKs
por: Alers, Sebastian, et al.
Publicado: (2012)

Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinase
por: Colamonici, Marco, et al.
Publicado: (2015)

ER-Targeted Beclin 1 Supports Autophagosome Biogenesis in the Absence of ULK1 and ULK2 Kinases
por: Anwar, Tahira, et al.
Publicado: (2019)

Perinatal versus adult loss of ULK1 and ULK2 distinctly influences cardiac autophagy and function
por: Harris, Matthew P., et al.
Publicado: (2022)

Phleboviruses and the Type I Interferon Response
por: Wuerth, Jennifer Deborah, et al.
Publicado: (2016)

A new tool for detection of type I interferon activation in systemic lupus erythematosus
por: Kirou, Kyriakos A, et al.
Publicado: (2010)

The Association of AMPK with ULK1 Regulates Autophagy
por: Lee, Jong Woo, et al.
Publicado: (2010)

The mammalian ULK1 complex and autophagy initiation
por: Zachari, Maria, et al.
Publicado: (2017)

Inhibitory effects of Tomivosertib in acute myeloid leukemia
por: Suarez, Milagros, et al.
Publicado: (2021)

Hantavirus Regulation of Type I Interferon Responses
por: Matthys, Valery, et al.
Publicado: (2012)

Stochastic dynamics of Type-I interferon responses
por: Maier, Benjamin D., et al.
Publicado: (2022)

Type I interferon
por: Niewold, Timothy B.
Publicado: (2020)

Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells
por: Booy, Stephanie, et al.
Publicado: (2014)

ULK1 as a novel therapeutic target in neurodegeneration
por: Vahsen, Björn Friedhelm, et al.
Publicado: (2020)

Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells
por: Saleiro, Diana, et al.
Publicado: (2023)

Tick-Borne Flaviviruses and the Type I Interferon Response
por: Lindqvist, Richard, et al.
Publicado: (2018)

LncRNAs in the Type I Interferon Antiviral Response
por: Suarez, Beatriz, et al.
Publicado: (2020)

Dysregulation of type I interferon responses in COVID-19
por: Acharya, Dhiraj, et al.
Publicado: (2020)

ULK4 in Neurodevelopmental and Neuropsychiatric Disorders
por: Luo, Shilin, et al.
Publicado: (2022)

Oligodendroglia are limited in type I interferon induction and responsiveness in vivo
por: Kapil, Parul, et al.
Publicado: (2012)

Phosphoproteomic identification of ULK substrates reveals VPS15‐dependent ULK/VPS34 interplay in the regulation of autophagy
por: Mercer, Thomas John, et al.
Publicado: (2021)

AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications
por: Vakana, Eliza, et al.
Publicado: (2011)

MNK Proteins as Therapeutic Targets in Leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
por: Eckerdt, Frank, et al.
Publicado: (2023)

Investigation of type I interferon responses in ANCA-associated vasculitis
por: Batten, Isabella, et al.
Publicado: (2021)

Editorial: Type I and Type III Interferon Immune Responses in Asthma
por: Finotto, Susetta, et al.
Publicado: (2022)

Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes
por: Apaolaza, Paola S., et al.
Publicado: (2021)

ULK1 and ULK2 are less redundant than previously thought: computational analysis uncovers distinct regulation and functions of these autophagy induction proteins
por: Demeter, Amanda, et al.
Publicado: (2020)

Type-I interferons in atherosclerosis
por: Chen, Hung-Jen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hcksncc5mbqtl5ka8deahlne94